Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) EBT Margin (2023 - 2025)

Immunocore Holdings' EBT Margin history spans 3 years, with the latest figure at 15.12% for Q4 2025.

  • For Q4 2025, EBT Margin rose 1441.0% year-over-year to 15.12%; the TTM value through Dec 2025 reached 4.77%, up 1229.0%, while the annual FY2025 figure was 4.77%, 1229.0% up from the prior year.
  • EBT Margin for Q4 2025 was 15.12% at Immunocore Holdings, down from 0.29% in the prior quarter.
  • Across five years, EBT Margin topped out at 7.59% in Q3 2024 and bottomed at 36.55% in Q4 2023.
  • The 3-year median for EBT Margin is 14.28% (2024), against an average of 15.53%.
  • The largest YoY upside for EBT Margin was 4063bps in 2025 against a maximum downside of -730bps in 2025.
  • A 3-year view of EBT Margin shows it stood at 36.55% in 2023, then increased by 19bps to 29.53% in 2024, then soared by 49bps to 15.12% in 2025.
  • Per Business Quant, the three most recent readings for IMCR's EBT Margin are 15.12% (Q4 2025), 0.29% (Q3 2025), and 9.9% (Q2 2025).